Immupharma PLC Notification of Major Interest in Shares (7716N)
October 03 2012 - 2:00AM
UK Regulatory
TIDMIMM
RNS Number : 7716N
Immupharma PLC
03 October 2012
FOR IMMEDIATE RELEASE 3 October 2012
ImmuPharma plc
(the "Company")
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying IMMUPHARMA PLC
issuer (ISIN = GB0033711010)
of existing shares to which voting rights
are
attached:
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights x
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------- -------
Other (please
specify):
------------------- -------------------------------------------------------- -------
3. Full name of person(s) subject ING Groep N.V.
to the
notification obligation:
----------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):
----------------------------------------
5. Date of the transaction and date 01 October 2012
on
which the threshold is crossed
or
reached:
----------------------------------------
6. Date on which issuer notified: 02 October 2012
----------------------------------------
7. Threshold(s) that is/are crossed
or
reached: 3%
----------------------------------------
8. Notified details:
A: Voting rights attached to shares
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
---------------------------------- -----------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
--------------- ----------------- ------------ ------------------------ -------------------------------
Direct Direct Indirect Direct Indirect
----- ------ ------ ----- ------------ ------------- --------- --------------- --------------
Ordinary
Shares
GB0033711010 2,462,669 2,462,669 2,445,669 2,445,669 0 2.9996% 2.9996%
--------------- ----------------- ------------ ------------- --------- --------------- --------------
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be
acquired if the
instrument is
exercised/ converted.
-------------- ------------------------------ --------------------------- ---------------------
N/A N/A N/A N/A N/A
-------------- ------------------------------ --------------------------- ---------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date Conversion rights instrument
instrument period refers to
------------- ------------- ---------------- ------------------------------ -------------------------
N/A N/A N/A N/A Nominal Delta
------------- ------------- ---------------- ----- ------------ -----------
N/A
----- ------ ------ ----- ---------- ------------------------------ ------------ -----------
Total (A+B+C)
Number of voting rights Percentage of voting rights
-----------------------------------------------------------
2,445,669 2.9996%
-----------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
N/A
Proxy Voting:
10. Name of the proxy holder: N/A
------------------------------
11. Number of voting rights proxy holder will N/A
cease
to hold:
------------------------------
12. Date on which proxy holder will cease to N/A
hold
voting rights:
------------------------------
13. Additional information: N/A
14. Contact name: Tracy Weimar, Vice President, Operations
and Company Secretary
-------------------------------------------
15. Contact telephone number: 020 7152 4080
-------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFIAILLFIIF
Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024
